Who is sponsoring NCT02151045?

NCT02151045 is sponsored by University Hospital, Montpellier.

What drugs are being tested in NCT02151045?

Interventions in NCT02151045: Non target epidural infiltration done at L3-L4 stage, Epidural infiltration on contact of disco radicular conflict.

What condition does NCT02151045 study?

NCT02151045 studies Discal Sciatica.

Is NCT02151045 still recruiting?

NCT02151045 is currently status unknown. Last updated 31 August 2015.

Last reviewed 2015-08-31 · How we verify

NCT02151045: EPI-AMELIE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of a Cortivazol (ALTIM®) Infiltration of Posterior Epidural Space at L3-L4 Stage Versus an Epidural Infiltration of Cortivazol (ALTIM®) on Contact With Disco Radicular Conflict in Discal Sciatica - Controlled Randomized Trial With Double Blind Evaluation

Status unknown Phase 3 Last updated 31 August 2015

What this trial tests

Phase 3 trial testing Non target epidural infiltration done at L3-L4 stage in Discal Sciatica in 112 participants. Status unknown.

Timeline

1 March 2012

Primary endpoint
1 March 2017

1 March 2017

Quick facts

Lead sponsor	University Hospital, Montpellier
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	112
Start date	1 March 2012
Primary completion	1 March 2017
Estimated completion	1 March 2017
Sites	2 locations across France

Drugs / interventions tested

Non target epidural infiltration done at L3-L4 stage
Epidural infiltration on contact of disco radicular conflict

Conditions studied

Discal Sciatica — all drugs for Discal Sciatica →

Sponsor

University Hospital, Montpellier

Who can join

Adults 18 to 65, any sex, with Discal Sciatica. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Pain evolution on analogic visual scale (EVA) ay Day 30
Time frame: at Day 30 after infiltration

Sponsor's own description

In discal sciatica, after failure of medical treatment, the investigators propose frequently a spinal infiltration of corticoids the most closer of disco-radicular conflict. Recently, some cases of paraplegia during lumbar foraminal infiltrations have induce a reduction of indications of this type of infiltration. An alternative would be to propose a lateral epidural infiltration on contact with conflict.The objective of this study is to compare, in 112 patients with a less than 6 months discal sciatica, the efficacy on pain of a non target posterior epidural space infiltration of corticoids done at L3-L4 stage on scan control versus an epidural infiltration of the same corticoid done in lateral on contact of disco radicular conflict on scan control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02151045 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 31 August 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02151045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing